Literature DB >> 8306025

Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy.

A Torres1, M el-Ebiary, L Padró, J Gonzalez, J P de la Bellacasa, J Ramirez, A Xaubet, M Ferrer, R Rodriguez-Roisin.   

Abstract

To assess the accuracy of clinical parameters for the diagnosis of ventilator-associated (VA) pneumonia, as well as the diagnostic value of several invasive techniques, such as protected specimen brush (PSB), bronchoalveolar lavage (BAL), fiberoptic bronchial aspirates (FBAS), and percutaneous lung needle aspiration (PLNA), we compared the results of these techniques with the histopathology of immediate postmortem pulmonary biopsies, considered the "gold standard" reference test. We studied 30 mechanically ventilated patients (age 52 +/- 21 yr; mechanical ventilation period 9 +/- 7 days) who died in an intensive care unit. All patients received prior antibiotic treatment. The following procedures were performed immediately after death: bilateral PSB, BAL, FBAS, and PLNA, as well as bilateral minithoracotomies to obtain pulmonary biopsies as close as possible to the area sampled with the other techniques. According to the histopathology 18 patients had pneumonia and 12 did not. The presence of fever (sensitivity 55%, specificity 58%), purulent secretions (sensitivity 83%, specificity 33%), and chest radiograph infiltrates (sensitivity 78%, specificity 42%) could not differentiate in all instances presence from absence of pneumonia. Quantitative bacterial cultures of lung biopsies using 10(3) cfu/g as a cutoff point had low sensitivity (40%) and low specificity (45%) and could not differentiate the histologic absence or presence of pneumonia. Considering the histopathology of pulmonary biopsies as a gold standard, we found the following sensitivities for PSB, BAL, FBAS, and PLNA: 36, 50, 44, and 25%. The specificities were 50, 45, 48, and 79%, respectively. The sensitivities and specificities of different invasive techniques are much lower than those reported in clinical studies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306025     DOI: 10.1164/ajrccm.149.2.8306025

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  48 in total

Review 1.  Diagnosis of pneumonia and monitoring of infection eradication.

Authors:  M Ruiz; C Arosio; P Salman; T T Bauer; A Torres
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 2.  Histopathology of ventilator-associated pneumonia (VAP) and its clinical implications.

Authors:  A Torres; N Fábregas; Y Arce; M A López-Boado
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

3.  Approaches to suspected ventilator-associated pneumonia: relying on our own bias.

Authors:  S Ewig; A Torres
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

4.  Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria.

Authors:  Elpis Giantsou; Nikolaos Liratzopoulos; Eleni Efraimidou; Maria Panopoulou; Eleonora Alepopoulou; Sofia Kartali-Ktenidou; George I Minopoulos; Spyros Zakynthinos; Konstantinos I Manolas
Journal:  Intensive Care Med       Date:  2005-09-07       Impact factor: 17.440

5.  [How often is bronchopneumonia overlooked as the cause of death in intensive care unit patients?].

Authors:  S Koch; J Bredahl; S P Wirtz; U R Jahn; S Gunia
Journal:  Anaesthesist       Date:  2008-01       Impact factor: 1.041

6.  Diagnosis of ventilator-acquired Pneumonia: Where Do We Go From Here?

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-03

7.  Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia.

Authors:  A Torres; M El-Ebiary; N Fábregas; J González; J P de la Bellacasa; C Hernández; J Ramírez; R Rodriguez-Roisin
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

8.  Ribosomal PCR assay of excised intervertebral discs from patients undergoing single-level primary lumbar microdiscectomy.

Authors:  Todd F Alamin; Marcus Munoz; Alicia Zagel; Agnes Ith; Eugene Carragee; Ivan Cheng; Gaetano Scuderi; Indre Budvytiene; Niaz Banei
Journal:  Eur Spine J       Date:  2017-05-31       Impact factor: 3.134

9.  Bilateral versus unilateral bronchoalveolar lavage for the diagnosis of ventilator-associated pneumonia.

Authors:  Mark A Jonker; Tina M Sauerhammer; Lee D Faucher; Michael J Schurr; Kenneth A Kudsk
Journal:  Surg Infect (Larchmt)       Date:  2012-12-16       Impact factor: 2.150

10.  Bacterial ventilator-associated pneumonia: bronchoalveolar lavage results are not influenced by dilution.

Authors:  Olivier Baldesi; Fabrice Michel; Christophe Guervilly; Nathalie Embriaco; Aliocha Granfond; Bernard La Scola; Henri Portugal; Laurent Papazian
Journal:  Intensive Care Med       Date:  2009-02-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.